Katerina Koniari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katerina Koniari has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Antonios Pitsis
Cardiac Surgery Department, Interbalkan Medical Center, Thessaloniki, Greece
1 shared publication Christos Hitas
Cardiology Department, Amalia Fleming General Hospital, Melissia, Attiki
1 shared publication- Dimitrios Iliopoulos
4th Cardiac Surgery Department, Hygeia Hospital, 15123 Athens, Greece
1 shared publication - Emmanouil P. Vardas
Department of Cardiology, Athens General Hospital G. Gennimatas , Athens
1 shared publication - Gregory Pattakos
Department of Cardiac Surgery, Hygeia Hospital, 4 Erythrou Stavrou St, Athens 15123, Greece
1 shared publication Ioannis Paraskevaidis
Attikon University Hospital, Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 5 March 2024
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 84, 13-21
Atrial fibrillation post CABG and the risk of arrhythmia recurrence: the AFRODITE study
- 5 March 2024
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 84, 13-21
Open AccessAtrial fibrillation post CABG and the risk of arrhythmia recurrence: the AFRODITE study
- Open Access
- 10 July 2012
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 1 (3) , 256-268
Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches
Most patients hospitalized for acutely decompensated heart failure (ADHF) present with symptoms and signs of volume overload, which is also associated with substantially high rates of death and rehospitalization in ADHF. To review the recent experimental and clinical evidence on existing therapeutic algorithms and investigational drugs used for the treatment of volume overload in ADHF patients. A systematic search of peer-reviewed publications was performed on Medline and EMBASE from January 1990 to March 2012. The results of unpublished trials were obtained from presentations at national and international meetings. Apart from intrinsic renal insufficiency and neurohormonal activation, volume overload through venous congestion may be the primary haemodynamic factor triggering the worsening of renal function in ADHF patients. It is well known that heart and kidneys are closely interrelated and an acute or chronic disorder in one organ may induce acute or chronic dysfunction in the other organ. Established therapeutic strategies, (e.g. loop diuretics, vasodilators, and inotropes), are sometimes associated with limited clinical success due to tolerance and the need for frequent up titration of the doses in order to achieve the desired effect. That leads to an increasing interest in novel options, such as the use of adenosine A1 receptor antagonists, vasopressin antagonists, and renal-protective dopamine. Initial clinical trials have shown quite encouraging results in some heart failure subpopulations but have failed to demonstrate a clear beneficial role of these agents. On the other hand, ultrafiltration appears to be a more promising therapeutic procedure that will improve volume regulation, while preserving renal and cardiac function. Further clinical studies are required in order to determine their net effect on renal function and potential cardiovascular outcomes. Until then, management of volume overload in ADHF patients remains a challenge for the clinicians.
- 10 July 2012
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 1 (3) , 256-268
Open AccessTreating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches
Most patients hospitalized for acutely decompensated heart failure (ADHF) present with symptoms and signs of volume overload, which is also associated with substantially high rates of death and rehospitalization in ADHF. To review the recent experimental and clinical evidence on existing therapeutic algorithms and investigational drugs used for the treatment of volume overload in ADHF patients. A systematic search of peer-reviewed publications was performed on Medline and EMBASE from January 1990 to March 2012. The results of unpublished trials were obtained from presentations at national and international meetings. Apart from intrinsic renal insufficiency and neurohormonal activation, volume overload through venous congestion may be the primary haemodynamic factor triggering the worsening of renal function in ADHF patients. It is well known that heart and kidneys are closely interrelated and an acute or chronic disorder in one organ may induce acute or chronic dysfunction in the other organ. Established therapeutic strategies, (e.g. loop diuretics, vasodilators, and inotropes), are sometimes associated with limited clinical success due to tolerance and the need for frequent up titration of the doses in order to achieve the desired effect. That leads to an increasing interest in novel options, such as the use of adenosine A1 receptor antagonists, vasopressin antagonists, and renal-protective dopamine. Initial clinical trials have shown quite encouraging results in some heart failure subpopulations but have failed to demonstrate a clear beneficial role of these agents. On the other hand, ultrafiltration appears to be a more promising therapeutic procedure that will improve volume regulation, while preserving renal and cardiac function. Further clinical studies are required in order to determine their net effect on renal function and potential cardiovascular outcomes. Until then, management of volume overload in ADHF patients remains a challenge for the clinicians.